home about us issues eReview media room français contact us

The Family Index is an ever growing collection that catalogues social science findings on family matters obtained from journals, books, and government surveys.

Tuesday, September 07, 2010 WEDNESDAY, APRIL 25, 2007 THURSDAY, APRIL 26, 2007 Breast Cancer and "The Pill" Dr. Chris Kahlenborn "Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer" Chris Kahlenborn, MD; Francesmary Modugno, PhD, MPh; Douglas M. Potter, PhD; and Walter B. Severs, PhD Dr. Chris Kahlenborn with intro by Andrea Mrozek Dr. Chris Kahlenborn - Part 2 Dr. Kahlenborn's slide show presentation "The pill and cancer: what women should know" by Andrea Mrozek National Post - Wednesday, May 2, 2007 ____________________________________________________ “Hasn’t the Pill been discussed enough?” When the Mayo Clinic Proceedings published “Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-Analysis,” the accompanying editorial in the peer-reviewed scientific journal asked why we have yet to achieve consensus on the risks and benefits of the Pill. It’s likely because there has not yet been a conclusive study. When the Women’s Health Initiative study of Hormone Replacement Therapy (HRT) was stopped back in 2002 it was because the risks of continuing the study exceeded the benefits. HRT and the Pill contain the same ingredients in different dosages. The main reason for stopping the HRT estrogen-progestin study was because of a 26% increase in breast cancer. This new research shows women on the Pill before having their first child have a 44% increased risk in breast cancer. Dr. Chris Kahlenborn, author of this new study, came to Ottawa to discuss his findings, published by the Mayo Clinic, a world-renowned medical centre. He discussed why early Pill use is a significant risk for the development of premenopausal breast cancer. Journalist Barbara Seaman calls our estrogen use “The Greatest Experiment Ever Performed on Women.” Even after decades, does the experiment continue? ____________________________________________________ Dr. Chris Kahlenborn Dr. Chris Kahlenborn is a medical doctor, specializing in internal medicine. Dr. Kahlenborn graduated from Penn State Medical University in 1988 and has been doing research on the effects of oral contraceptives on breast cancer for well over ten years. He continues to see patients as well as travelling the world to give seminars and provide information on this important aspect of women’s health. Thus far he has spoken in Russia, China, the Philippines and Canada, as well as in the United States. In June 2000 he testified on this topic before the Federal Drug Administration (FDA) in Washington D.C. His most recent publication, published in the Mayo Clinic Proceedings in October, 2006 is called “Oral Contraceptive use as a risk factor for premenopausal breast cancer.” The results of this study remain the focus of some media attention, resulting in stories in Glamour and Redbook, two popular women’s magazines as well as a piece in the National Post on October 20, 2006. He lives in Camp Hill, Pennsylvania with his wife. ____________________________________________________ Photos - Breast Cancer Awareness Seminar

Unsubscribe upcoming events past events 2010 Family Policy Conference Private Choices, Public Costs: Parliamentary Briefing June 3 2009 Family Policy Conference Jack Mintz on Income Splitting 2007 Family Policy Conference Breast Cancer Awareness Seminar Palliative Care Seminar First Annual Family Policy Conference Canadian Marriage Policy Reception Grand Opening

Sumation™ WebSite by quinix technologies